SoFi Technologies has surged on fintech growth and rate cut tailwinds, but rich valuation and raises caution. Learn why SOFI ...
Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator. Tolebrutinib ...
Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
GMAT/GRE is optional, but preferred. a limited number of scholarships are available and preference will be given to students who submit their GMAT/GRE scores. Learn more by clicking Application ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results